-

Medical Device Manufacturing Non-Conformance and Corrective Action Training Course: ISO 13485 and 21 CFR 820 - A Guide to Transparent QMS Practice (ONLINE EVENT: July 18, 2025) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Conformance and Corrective Action for Medical Device Manufacturers Training Course" training has been added to ResearchAndMarkets.com's offering.

The identification of non-conformances and ensuring that they are dealt with in a timely and appropriate manner is a key part of any medical device Quality Management System (QMS). Regulations for medical device quality management systems include particular requirements for non-conformance, correction, corrective and preventative actions.

These requirements relate to non-conformances identified through internal audits, external audits, routine processes, customer complaints vigilance and many other activities. Evidence of a QMS which deals with non-conformance and prevents recurrence is important and expected when demonstrating conformity with the regulations.

This course provides an introduction to these regulatory requirements as they relate to the identification and handling of non-conformances and how manufacturers may demonstrate compliance. These requirements are defined in ISO 13485, the international standard for medical device quality management systems, as well as in 21 CFR 820 and other global regulations.

Benefits of Attending

  • Understand the sources of non-conformance within a medical device QMS
  • Learn techniques to establish the root cause of a non-conformance
  • Understand the difference between containment, correction, corrective action, and preventative action
  • Gain an awareness of the ways in which an effective Corrective and Preventative Action (CAPA) system can lead to improved performance and regulatory compliance

Certification:

  • CPD: 3 hours for your records
  • Certificate of completion

Who Should Attend:

  • Managers and supervisors working within a regulated Quality Management System (QMS)
  • Regulatory Compliance specialists
  • Quality Management System (QMS) specialists
  • Internal Auditors
  • Regulatory and Quality professionals

Key Topics Covered:

Non-Conformance and Corrective Action

  • Regulatory requirements for non-conformance and corrective action
  • Definitions and understanding CAPA
  • Sources of non-conformance and writing an effective statement of non-compliance
  • The non-conformance and corrective action cycle
  • Assessment of the risk associated with non-compliance
  • Root cause analysis tools and methodology
  • Correction, containment and impact assessment
  • Taking effective corrective action to address root causes
  • Evaluation of the effectiveness of corrective action
  • Use of electronic quality management systems for non-conformance management

Preventive Action

  • Regulatory requirements for identification of preventive action
  • Sources of preventive action and how to capture the details
  • Root cause analysis
  • Evaluation of the effectiveness of preventive action

For more information about this training visit https://www.researchandmarkets.com/r/tzkpkv

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Non-Opioid Therapeutics Market Insights, Shares and Growth Outlook 2025-2032: Rising Integration of Non-Opioid Options in Multimodal Pain Management Protocols - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Opioid Therapeutics Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. This market research report focuses on the evolving landscape of the Non-Opioid Therapeutics Market. This sector has grown from USD 40.77 billion in 2024 to USD 43.78 billion in 2025, with projections suggesting a CAGR of 7.68% leading to a valuation of USD 73.72 billion by 2032. Non-opioid therapeutics have become critical in modern pain management, add...

Disulfiram Market Report 2025-2032: Growth Forecast, Segment Shares, FPNV Positioning Matrix and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Disulfiram Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The Disulfiram Market is advancing in scope and strategic significance as evolving clinical practices, regulatory shifts, and technology continue to reframe substance use disorder management. Senior executives must navigate opportunities and risks shaped by global healthcare transformation, positioning their organizations for competitive relevance. Market Snap...

Instant Hot Pot Self-Heating Rice Market Analysis 2025-2032: Emerging Trends, Market Share Analysis, FPNV Positioning Matrix - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Instant Hot Pot Self-Heating Rice Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The instant hot pot self-heating rice market is evolving rapidly, as global consumers increasingly seek convenient meal solutions that deliver authentic taste and consistent quality. Advancements in self-heating technology and dynamic shifts in consumer lifestyles are driving substantial growth across multiple regions and segments. Marke...
Back to Newsroom